Linsuan Paiqin Baota Tang (磷酸哌嗪宝塔糖)磷酸哌嗪宝塔糖
This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。
Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。
生产企业Manufacturer
- 四川德元药业集团有限公司Chinese legal name: 四川德元药业集团有限公司
主要成分Active Ingredients
- 哌嗪 辅料为蔗糖Recorded Chinese composition: 哌嗪 辅料为蔗糖
- 明胶Ming Jiao
- 香精Xiang Jing
- 哌嗪Pai Qin
- 辅料为蔗糖Recorded Chinese composition: 辅料为蔗糖
药物知识说明
哌嗪 辅料为蔗糖是一种在国家药监局注册认定的药品。该药品含有哌嗪、哌嗪、明胶-c141ee52等成分。
该药品关联的活性成分包括：哌嗪Pai Qin、哌嗪Pai Qin、明胶Ming Jiao、香精Xiang Jing。这些成分信息来自国家药监局数据库。
该药品标注的生产企业为：四川德元药业集团有限公司Chinese legal name: 四川德元药业集团有限公司。
您可以探索含有相同成分的其他药品：哌嗪-f1f71c19成分药品。
本页面内容来自国家药监局数据库，MedicineGraph在此基础上提供关系图谱和知识导航。
Medicine Knowledge
This medicine (original name: 磷酸哌嗪宝塔糖) is a medicine registered with the national drug regulatory authority. It contains recorded ingredients as active ingredient(s).
Active ingredients associated with this product: 哌嗪Pai Qin, 哌嗪Pai Qin, 明胶Ming Jiao, 香精Xiang Jing.
Manufacturers recorded for this product: 四川德元药业集团有限公司Chinese legal name: 四川德元药业集团有限公司.
Explore other medicines containing the same ingredient: 哌嗪 productsProducts containing this recorded ingredient.
Source: MedicineGraph authoritative database. Relationships derived from registered product information.
这是什么What is this
- 通用名/品名Recorded product name: 磷酸哌嗪宝塔糖Recorded Chinese name: 磷酸哌嗪宝塔糖
- 规格Specification: 0.2g0.2 g
本段仅展示注册/说明书已记录的身份属性，不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.
主要成分Ingredients
生产企业Manufacturer
- 四川德元药业集团有限公司Chinese legal name: 四川德元药业集团有限公司
注册信息NMPA approval number
- 批准文号NMPA approval number: 国药准字H51023526
关联实体Relationships
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.
- 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
- 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.
本段为已核准说明书原文摘录（非改写、非AI摘要），非正式英文标签，亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.
English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.
NMPA approval number
国药准字H51023526
Manufacturer
Chinese legal name: 四川德元药业集团有限公司 (domestically manufactured)
Indications
English translation unavailable. The original Chinese source label remains available below.
Dosage and administration
English translation unavailable. The original Chinese source label remains available below.
Adverse reactions
English translation unavailable. The original Chinese source label remains available below.
Contraindications
English translation unavailable. The original Chinese source label remains available below.
Precautions
English translation unavailable. The original Chinese source label remains available below.
Storage
Keep sealed.
Specification
English translation unavailable. The original Chinese source label remains available below.
中文说明书原文Original Chinese source label
批准文号
国药准字H51023526
生产企业
四川德元药业集团有限公司(国产)
适应症
用于儿童蛔虫和蛲虫感染。
用法用量
口服. 驱蛔虫 一次每公斤体重0.08～0.13g，一日量不超过2.5g，连服2日。 驱蛲虫 一日每公斤体重0.05g，分2次服，一日量不得过2g，连服7～10日。
不良反应
1．偶见发生恶心、呕吐、腹痛、腹泻、头痛、感觉异常、荨麻疹等，停药后很快消失。
2．过敏者可发生流泪、流涕、咳嗽、眩晕、嗜睡、哮喘等。
3．偶见病毒性肝炎样表现、瞳孔缩小、调节障碍、麻痹性斜视等。
禁忌
肝肾功能不全、神经系统疾患或癫痫患者禁用。
注意事项
1.对本品过敏者禁用。
2．本品对人体(特别是儿童)具潜在神经肌肉毒性，应避免长期或过量便用。
3．营养不良或贫血者应先予纠正，再开始服用本品。
4．如服用过量或出现严重不良反应，请立即就医。
5．当本品性状发生改变时禁止服用。
6．儿童必须在成人监护下使用。
7．请将此药品放在儿童不能接触的地方。
贮藏
密封。
规格
0.2g
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据。National Medical Products Administration (China) medicine-registration data.
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.